메뉴 건너뛰기




Volumn 41, Issue 10, 2003, Pages 983-990

Immunogenicity of an Accelerated Vaccination Regime with a Combined Hepatitis A/B Vaccine in Patients with Chronic Hepatitis C

Author keywords

Accelerated vaccination; Hepatitis A B vaccine; Hepatitis C virus infection

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

EID: 0242268603     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42929     Document Type: Article
Times cited : (30)

References (27)
  • 1
    • 0001822571 scopus 로고
    • Global impact of hepatitis A virus infection: Changing patterns
    • Hollinger F, Lemon S, Margolis HS (Hrsg). Baltimore: Williams and Wilkins
    • Hadler SC. Global impact of hepatitis A virus infection: Changing patterns. In: Hollinger F, Lemon S, Margolis HS (Hrsg). Viral Hepatitis and Liver Disease. Baltimore: Williams and Wilkins, 1991: 14-20
    • (1991) Viral Hepatitis and Liver Disease , pp. 14-20
    • Hadler, S.C.1
  • 2
    • 0006198705 scopus 로고
    • Immunization strategies for the control of hepatitis A in the United States
    • Hollinger F, Lemon S, Margolis HS (Hrsg). Baltimore: Williams and Wilkins
    • Margolis HS, Hadler S, Shapiro C et al. Immunization strategies for the control of hepatitis A in the United States. In: Hollinger F, Lemon S, Margolis HS (Hrsg). Viral Hepatitis and Liver Disease. Baltimore: Williams and Wilkins, 1991: 21-30
    • (1991) Viral Hepatitis and Liver Disease , pp. 21-30
    • Margolis, H.S.1    Hadler, S.2    Shapiro, C.3
  • 3
    • 0028814888 scopus 로고
    • Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?
    • Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 1995; 90: 201-205
    • (1995) Am J Gastroenterol , vol.90 , pp. 201-205
    • Keeffe, E.B.1
  • 4
    • 0032576759 scopus 로고    scopus 로고
    • Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C
    • Vento S, Garofano T, Renzini C et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. New Engl J Med 1998; 338: 286-290
    • (1998) New Engl J Med , vol.338 , pp. 286-290
    • Vento, S.1    Garofano, T.2    Renzini, C.3
  • 5
    • 0034956892 scopus 로고    scopus 로고
    • Risks associated with hepatitis A and hepatitis B in patients with hepatitis C
    • Koff RS. Risks associated with hepatitis A and hepatitis B in patients with hepatitis C. J Clin Gastroenterol 2001; 331 (1): 20-26
    • (2001) J Clin Gastroenterol , vol.331 , Issue.1 , pp. 20-26
    • Koff, R.S.1
  • 6
    • 0033784969 scopus 로고    scopus 로고
    • Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection
    • Liaw YF, Yeh CT, Tsai SL. Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol 2000; 95 (10): 2978-2980
    • (2000) Am J Gastroenterol , vol.95 , Issue.10 , pp. 2978-2980
    • Liaw, Y.F.1    Yeh, C.T.2    Tsai, S.L.3
  • 7
    • 0000380476 scopus 로고    scopus 로고
    • Impfempfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut
    • Robert Koch Institut (Hrsg)
    • Impfempfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. In: Robert Koch Institut (Hrsg). Epidemiologisches Bulletin 1998; 15: 101-112
    • (1998) Epidemiologisches Bulletin , vol.15 , pp. 101-112
  • 8
    • 0031021442 scopus 로고    scopus 로고
    • Vaccines to prevent viral hepatitis
    • Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. New Engl J Med 1997; 336 (3): 196-200
    • (1997) New Engl J Med , vol.336 , Issue.3 , pp. 196-200
    • Lemon, S.M.1    Thomas, D.L.2
  • 9
    • 0031915859 scopus 로고    scopus 로고
    • Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
    • Keeffe EB, Iwarson S, McMahon B et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998; 27: 881-886
    • (1998) Hepatology , vol.27 , pp. 881-886
    • Keeffe, E.B.1    Iwarson, S.2    McMahon, B.3
  • 10
    • 0030927093 scopus 로고    scopus 로고
    • Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease
    • Lee SD, Chan CY, Yu MI et al. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease. J Med Virol 1997; 52: 215-218
    • (1997) J Med Virol , vol.52 , pp. 215-218
    • Lee, S.D.1    Chan, C.Y.2    Yu, M.I.3
  • 11
    • 0032974080 scopus 로고    scopus 로고
    • Immunogenicity of hepatitis A vaccine in decompensated liver disease
    • Dumot J, Barnes D, Younossi Z et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol 1999; 94: 1601-1604
    • (1999) Am J Gastroenterol , vol.94 , pp. 1601-1604
    • Dumot, J.1    Barnes, D.2    Younossi, Z.3
  • 12
    • 0031667589 scopus 로고    scopus 로고
    • Hepatitis B vaccination of patients with chronic liver disease
    • Keeffe EB, Krause DS. Hepatitis B vaccination of patients with chronic liver disease. Liver Transplant Surg 1998; 4: 437-439
    • (1998) Liver Transplant Surg , vol.4 , pp. 437-439
    • Keeffe, E.B.1    Krause, D.S.2
  • 13
    • 0033970794 scopus 로고    scopus 로고
    • Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C
    • Wiedmann M, Liebert UG, Oesen U et al. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology 2000; 31: 230-234
    • (2000) Hepatology , vol.31 , pp. 230-234
    • Wiedmann, M.1    Liebert, U.G.2    Oesen, U.3
  • 14
    • 0031831046 scopus 로고    scopus 로고
    • Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers
    • Reutter J, Bart P, Francioli P et al. Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers. J Viral Hepatol 1998; 5: 205-211
    • (1998) J Viral Hepatol , vol.5 , pp. 205-211
    • Reutter, J.1    Bart, P.2    Francioli, P.3
  • 15
    • 0345435056 scopus 로고    scopus 로고
    • The first combined vaccine against hepatitis A and B: An overview
    • Thoelen S, Van Damme P, Leentvaar-Kuypers A et al. The first combined vaccine against hepatitis A and B: an overview. Vaccine 1999; 17: 1657-1662
    • (1999) Vaccine , vol.17 , pp. 1657-1662
    • Thoelen, S.1    Van Damme, P.2    Leentvaar-Kuypers, A.3
  • 16
    • 0343090826 scopus 로고    scopus 로고
    • Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?
    • Kallinowski B, Knöll A, Lindner E et al. Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course? Vaccine 2001; 19: 16-22
    • (2001) Vaccine , vol.19 , pp. 16-22
    • Kallinowski, B.1    Knöll, A.2    Lindner, E.3
  • 17
    • 0036150128 scopus 로고    scopus 로고
    • A two-dose combined vaccine against hepatitis A and hepatitis B in healthy children and adolescents compared to the corresponding monovalent vaccines
    • Ramonet M, da Silveira TR, Lisker-Melman M et al. A two-dose combined vaccine against hepatitis A and hepatitis B in healthy children and adolescents compared to the corresponding monovalent vaccines. Arch Med Res 2002; 33: 67-73
    • (2002) Arch Med Res , vol.33 , pp. 67-73
    • Ramonet, M.1    Da Silveira, T.R.2    Lisker-Melman, M.3
  • 18
    • 0037081543 scopus 로고    scopus 로고
    • A new accelerated vaccination schedule for rapid protection against hepatitis A and B
    • Nothdurft H, Dietrich M, Zuckermann J et al. A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine 2002; 20: 1157-1162
    • (2002) Vaccine , vol.20 , pp. 1157-1162
    • Nothdurft, H.1    Dietrich, M.2    Zuckermann, J.3
  • 19
    • 0033559027 scopus 로고    scopus 로고
    • Influenza vaccination in liver transplant recipients
    • Burbach G, Bienzle U, Stark K et al. Influenza vaccination in liver transplant recipients. Transplantation 1999; 67: 753-755
    • (1999) Transplantation , vol.67 , pp. 753-755
    • Burbach, G.1    Bienzle, U.2    Stark, K.3
  • 20
    • 0030998124 scopus 로고    scopus 로고
    • Routine immunizations in adult renal transplant recipients
    • Huzly D, Neifer S, Reinke P et al. Routine immunizations in adult renal transplant recipients. Transplantation 1997; 63: 839-845
    • (1997) Transplantation , vol.63 , pp. 839-845
    • Huzly, D.1    Neifer, S.2    Reinke, P.3
  • 21
    • 0036901212 scopus 로고    scopus 로고
    • The effect of age on immunologic response to recombinant hepatitis B vaccine: A meta-analysis
    • Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis 2002; 35 (11): 1368-1375
    • (2002) Clin Infect Dis , vol.35 , Issue.11 , pp. 1368-1375
    • Fisman, D.N.1    Agrawal, D.2    Leder, K.3
  • 22
    • 0035723859 scopus 로고    scopus 로고
    • Increased effective immunogenicity to high dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosis
    • De Maria N, Idilman R, Colantoni A et al. Increased effective immunogenicity to high dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosis. J Viral Hepat 2001; 8: 372-376
    • (2001) J Viral Hepat , vol.8 , pp. 372-376
    • De Maria, N.1    Idilman, R.2    Colantoni, A.3
  • 23
    • 0036175360 scopus 로고    scopus 로고
    • The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C
    • Idilman R, De MN, Colantoni A et al. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C. Am J Gastroenterol 2002; 97 (28): 435-439
    • (2002) Am J Gastroenterol , vol.97 , Issue.28 , pp. 435-439
    • Idilman, R.1    De, M.N.2    Colantoni, A.3
  • 24
    • 0029796150 scopus 로고    scopus 로고
    • Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults
    • Leroux-Roels G, Moreau W, Desombere I et al. Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults. Scand J Gastroenterol 1996; 31: 1027-1031
    • (1996) Scand J Gastroenterol , vol.31 , pp. 1027-1031
    • Leroux-Roels, G.1    Moreau, W.2    Desombere, I.3
  • 25
    • 0036460651 scopus 로고    scopus 로고
    • Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/HiB vaccine compared to separate comcomitant injections of DTPa-IPV/HiB and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule
    • Avdicova M, Prikazsky VV, Hudeckova H et al. Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/HiB vaccine compared to separate comcomitant injections of DTPa-IPV/HiB and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule. Eur J Pediatr 2002; 161 (11): 581-587
    • (2002) Eur J Pediatr , vol.161 , Issue.11 , pp. 581-587
    • Avdicova, M.1    Prikazsky, V.V.2    Hudeckova, H.3
  • 26
    • 0035860588 scopus 로고    scopus 로고
    • A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (TwinrixTM) with corresponding monovalent vaccines (HavrixTM and Engerix-BTM) in adults
    • Joines RW, Blatter M, Abraham B et al. A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (TwinrixTM) with corresponding monovalent vaccines (HavrixTM and Engerix-BTM) in adults. Vaccine 2001; 19: 4710-4719
    • (2001) Vaccine , vol.19 , pp. 4710-4719
    • Joines, R.W.1    Blatter, M.2    Abraham, B.3
  • 27
    • 84994984304 scopus 로고
    • Accelerated schedule for hepatitis B immunization
    • Bock HL, Löscher T, Scheiermann N et al. Accelerated schedule for hepatitis B immunization. J Travel Med 1995; 7: 213-217
    • (1995) J Travel Med , vol.7 , pp. 213-217
    • Bock, H.L.1    Löscher, T.2    Scheiermann, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.